 | ||||||
| Gustav
KLIMT, The Three Ages of a Woman, 1905 | ||||||
|
| International
Conference on
The Austrian Society for Bone and Mineral Research announces its 2003 INTERNATIONAL RESEARCH PRIZE | ||||||||||
|
|
| |||||||||||||||||||||||||||||
|
|
| Lectures and Submitted Papers |
| Thursday, November 27, 2003 |
| 8.30 | 1 | "The
essential role of FGF-23 in phosphate and vitamin D metabolism" T. Yamashita Pharmaceutical Research Labs, KIRIN Brewery Co., Ltd., Japan |
| 8.50 | 2 |
"Pathophysiology of the extracellular calcium-sensing receptor (CaR)" E.M. Brown, O. Kifor, N. Chattopadhyay, R.J. MacLeod, J. Tfelt-Hansen, S. Yano, F.D. Moore, R.R. Butters Division of Endocrinology, Diabetes and Hypertension, Membrane Biology Program, Departments of Medicine and Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA |
| 9.20 | 3 |
"The extracellular
calcium-sensing receptor in mouse colon - induction of expression by low dietary
calcium" E. Kállay, M. Zeitelhofer, H.S. Cross Dept. of Pathophysiology, University of Vienna Medical School, Vienna, Austria |
| 9.30 | 4 |
"Age- and
dietary calcium-related induction of 25-D3-24-hydroxylase expression in the mouse
colon - relevance for colon tumor incidence and prevention" H.S. Cross, E. Kallay, M. Peterlik Institute of Pathophysiology, University of Vienna Medical School, Vienna, Austria |
| 9.40 | 5 |
"Calcium,
vitamin D and estrogen - why they are good for prevention of osteoporosis and
colorectal cancer" M. Peterlik, H.S. Cross Department of Pathophysiology, University of Vienna Medical School, Vienna, Austria |
| 10.10 | 6 |
"Genetic disposition for adult lactose intolerance, calcium metabolism,
bone density, and bone fractures" B.M. Obermayer-Pietsch1, C.M. Bonelli1, D.E. Walter1, R.J. Kuhn1, A. Fahrleitner-Pammer1, A. Berghold2, W. Goessler3, V. Stepan1, H. Dobnig1, W. Renner4, G. Leb1 1Department of Internal Medicine, Karl-Franzens University, Graz, Austria, 2Institute for Medical Informatics, Statistics and Documentation, Karl-Franzens University, Graz, Austria, 3Institute of Chemistry - Analytical Chemistry, Karl-Franzens University, Graz, Austria, 4Institute of Molecularbiological Analytics, Graz, Austria |
| 10.20 | 7 | "
Serum level of osteocalcin predicts progression to osteoporosis in osteopenic
women - JPOS cohort study" M. Iki1, T. Akiba2, T. Matsumoto3, S. Kagamimori4, Y. Kagawa5, H. Yoneshima6 1Department of Public Health, Kinki University School of Medicine 377, Osaka, Japan; 2Tokyo Women's Medical College, Tokyo, Japan; 3Tokushima University, Tokushima, Japan; 4Toyama Medical & Pharmaceutical University, Toyama, Japan; 5Kagawa Nutrition University, Tokyo, Japan; 6Kasukabe Shuuwa Hospital, Kasukabe, Japan |
| 10.30 - 11.00 | Coffee Break - Poster Viewing |
| 11.00 | 8 |
"Normative values of soluble RANKL in the serum of healthy adults and
correlation with various parameters of bone metabolism" S. Kudlacek1,2, B. Schneider3, W. Woloszczuk2,5, P. Pietschmann2,4, R. Willvonseder1,2 for the Austrian Study Group on Normative Values of Bone Metabolism 1) Medizinische Abteilung, Krankenhaus der Barmherzigen Brüder, Vienna, Austria, 2) Ludwig Boltzmann Institut für Altersforschung, Vienna, Austria, 3) Institut für Medizinische Statistik, University Vienna, Austria, 4) Institut für Pathophysiologie, University Vienna, Austria, 5) Ludwig Boltzmann Institut für experimentelle Endokrinologie, Vienna, Austria |
| 11.10 | 9 |
"Serum osteoprotegerin
and sRANKL levels in men with differentiated thyroid cancer receiving suppressive
L-thyroxine treatment - preliminary results" P. Mikosch1,2, I. Igerc1, S. Kudlacek3, W. Woloszczuk4, G. Grimm2, P. Lind1, P. Pietschmann5 1Department of Nuclear Medicine and Special Endocrinology, Klagenfurt State Hospital, Austria, 2Department of Internal Medicine II, Klagenfurt State Hospital, 3Department of Medicine, Hospital Bamherzige Brüder Wien, Vienna, Austria, 4Ludwig Bolzmann-Institute of Experimental Endocrinology, Vienna, Austria, 5Department of Pathophysiology, University of Vienna, Austria |
| 11.20 | 10 |
"Is bone metabolism affected by the human thyroid stimulating hormone
TSH? Preliminary results from a clinical study in patients with TSH-suppressive
thyroid hormone therapy" H.P. Dimai*, C. Piswanger-Soelkner*, A. Fahrleitner*, S. Ramschak-Schwarzer*, H. Wenisch*, M. Gugatschka, G. Leb* *University Clinic Graz, Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Graz, Austria |
| 11.30 | 11 |
"OPG an sRANKL in rheumatoid arthritis and osteoarthritis: serum and synovium
concentrations" G. Hawa1, N. Brinskelle-Schmal1, M. Skoumal2, G. Kolarz2, W. Woloszczuk3 1Biomedica Medizinprodukte GmbH & Co KG, Vienna, Austria, 2Institut für Rheumatologie der Kurstadt Baden in Kooperation mit der Donauuniversität Krems & Rheumasonderkrankenanstalt der SVA der gewerblichen Wirtschaft, Baden, Austria, 3Ludwig Boltzmann Institut für Experimentelle Endokrinologie, Vienna, Austria |
| 11.40 | 12 |
"Congenital hip dysplasia and disturbances of bone and connective tissue
in adult female patients" C.M. Bonelli, D. Walter, A. Fahrleitner, C. Piswanger Sölkner, H. Dobnig, W. Linhart, T. Reitinger, R. Windhager, G. Leb, B. Obermayer-Pietsch Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Karl Franzens University, Graz, Austria |
| 11.50 | 13 |
"Sex hormone-binding globulin is negatively correlated with femoral bone
mineral density in cardiac transplant recipients" G. Höfle, G. Tautermann, C. Säly, H. Drexel Department of Internal Medicine and VIVIT Institute, Academic Teaching Hospital Feldkirch, Feldkirch, Austria |
| 12.00 | 14 |
"Diabetes mellitus in institutionalized patients is associated with higher
bone mass measured by ultrasonography as well as lower iPTH levels and markers
of bone turnover" M. Roth, A. Fahrleitner, C. Piswanger-Sölkner, B. Obermayer-Pietsch, G. Leb, H. Dobnig Division of Endocrinology and Nuclear Medicine, Karl Franzens University, Graz, Austria |
| 12.10 | 15 |
"Severe osteopathy with low mineralization density and multiple spine
fractures in a girl with Desmin-myopathy: follow up after vitamin D and calcium
supplementation" E. Biber1 , P. Roschger3, J. Haller3, A. Nader3, J. Wanschitz2, K. Klaushofer3, H. Resch1 1Department of Internal Medicine, KH Barmherzige Schwestern (St. Vincent), 2Department of Clinical Neuropathology, University Vienna , 3Ludwig Boltzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria |
| 12.20 | 16 |
"Bone mineral density and bone metabolism in patients with schizophrenia" R.W. Gasser1), M. Hummer2), P. Malik2), G. Finkenstedt1), A. Hofer2), G. Kemmler2), R.C. Moncayo Naveda3), M. Oehl2), W.W. Fleischhacker2) Departments of 1)Internal Medicine, 2)Biological Psychiatry and 3)Nuclear Medicine, University of Innsbruck, Austria |
| 12.30 | 17 |
"The relationship between bone fracture experience and public participation
in the elderly inhabitants" E. Kajita, N. Gounai, M. Eto (Dept. of Public Health and Home Nursing, Nagoya University School of Health Sciences, Nagoya, Japan), Y. Nakatani (Dept. of Community Nursing, Hamamatsu University School of Medicine, Hamamatsu, Japan), I. Matsubara (Ishikawa prefectural Nursing University, Kanazawa, Japan), S. Kagamimori (Dept. of Welfare Promotion and Epidemiology, School of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan) |
| 12.40 | 18 |
"Biomarker effects of a vitamin D analog, RO0275646 in postmenopausal
women, with minimal effects on calcium homeostasis" G. Hill1, R. Robson2, F. Höppener3, S. Holt4, T. Tarnowski1, Z. Avnur1, D. Ipe1 , N. Berger1, R. Lal1, R. Daley1, R. Yuan1, M. Brandl1, A. Ahene1, G. Hisoire1, J. Yee1 1Roche Palo Alto, CA; 2CCST, New Zealand; 3Kendle, Netherland; and 4P3, New Zealand |
| 12.50 | 19 |
"Effect of 2 beta-(3-Hydroxypropoxy) -calcitriol on bone mass and strenght
and bone metabolism in ovariectomized mice" Y. Xue, H. Tan, Q. Wang et al. Department of Biochemistry, Beijing Ji Shui Tan Hospital, Beijing, China |
| 13.00 | 20 |
"Treatment of osteopenic ovariectomized (OVX) rats with a combination
of PTH-(1-34) and OPG leads to elevated bone volume and increased uniformity in
bone mineralization" A. Valenta1,2, P. Roschger1, N. Fratzl-Zelman1, P.J. Kostenuik3, C.R. Dunstan3, P. Fratzl4, K. Klaushofer1 1Ludwig Boltzmann Institute of Osteology, 4th Med. Department, Hanusch Hospital and UKH Meidling, Vienna, Austria, 2Erich Schmid Institute of Materials Science, Austrian Academy of Sciences and Institute of Metal Physics, University of Leoben, Leoben, Austria, 3Metabolic Disorders Research, AMGEN, Inc., Thousand Oaks, California, USA, 4Max Planck Institute of Colloids and Interfaces, Dept. Biomaterials, Potsdam, Germany |
| 13.10 - 14.00 | Lunch |
| 14.00 | 21 |
"Prostaglandins and bone" L.G. Raisz University of Connecticut Health Center, Farmington, CT, USA |
| 14.20 | 22 |
"ET-1 induced expression of PGHS-2 in MC3T3-E1 osteoblast-like cells" W. Windischhofer, D. Zach, G. Fauler, G.N. Rechberger, H.J. Leis Univ. Children´s Hospital Graz; Div. Analyt. Biochem. & Mass Spectrometry; Graz, Austria |
| 14.30 | 23 |
"Disintegrins and osteoblastic prostaglandin E2 synthesis" H.J. Leis, W. Windischhofer, G. Fauler, D. Zach, G. Raspotnig Univ. Children's Hospital, Division of Biochemical Analysis and Mass Spectrometry, Graz, Austria |
| 14.40 | 24 |
"Novel signaling pathways in bone cells" P.H. Stern Department of Molecular Pharmacology, Northwestern Unbiversity Medical School, Chicago, IL, USA |
| 15.00 | 25 |
"Endothelin A receptor-mediated calcium mobilization in a clonal
murine osteoblast-like cell line, MC3T3-E1/B" D. Zach, W. Windischhofer, G. Rechberger, G. Fauler, G. Raspotnig, H. Köfeler, H.J. Leis Univ. Children's Hospital Graz, Graz, Austria |
| 15.10 | 26 |
"Platelet-released supernatants are mitogenic and chemoattractant for
mesenchymal progenitor cells - involvement of PDGF and mitogen-activated protein
kinase signaling" #+R. Gruber, +F. Karreth, +B. Kandler, §A. Rot, *M.B. Fischer, #+G. Fürst, #+G. Watzek +Department of Oral Surgery, Dental School, University of Vienna, Austria, #Ludwig Boltzmann Institute of Oral Implantology, Vienna, Austria, *Department of Transfusion Medicine, University of Vienna, Austria, $Novartis Forschungsinstitut, Vienna, Austria |
| 15.20 | 27 |
"Both N- and C-terminal paratyroid hormone-related protein exert biphasic
effects on human osteoblast differentiation in vitro" A.R. De Gortázar, I. del Valle*, C. Guillén, M.E. Martínez*, P. Esbrit Laboratorio de Metabolismo Mineral y Óseo, Fundación Jiménez Díaz, *Unidad de Metabolismo Óseo-Departamento de Bioquímica, Hospital La Paz, Madrid, Spain |
| 15.30 | 28 |
"Identification of an estrogen responsive element in the osteoprotegerin
promoter" M. Rumpler, F. Varga, P. Nemeth, K. Klaushofer Ludwig Boltzmann Institute of Osteology, 4th Med. Dept., Hanusch Hospital, Vienna, Austria |
| 15.40 | 29 |
"Growth hormone action on bone cells: modulator of a functional Runx2/Cbfa1-Stat3b
interaction" P.G. Ziros1, T. Georgakopoulos1, I. Habeos1, E.K. Basdra2, A.G. Papavassiliou1 1Department of Biochemistry, School of Medicine, University of Patras, 26110 Patras, Greece, 2Department of Orthodontics, Heidelberg University, 69120 Heidelberg, Germany |
| 15.50 | 30 |
"Triiodothyronine (T3) regulates osteocalcin (OCN) promoter activity in
NIH3T3 fibroblasts" F. Varga, S. Spitzer, K. Klaushofer Ludwig Boltzmann Institute of Osteology, 4th Med. Dept. Hanusch Hospital, Vienna, Austria |
| 16.00 - 16.30 | Coffee Break - Poster Viewing |
| 16.30 | 31 |
"Osteoblast differentiation and chromatin remodeling by nuclear receptors" S. Kato, M. Suzawa, H. Kitagawa The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, SORST, Japan Science and Technology Corporation, Saitama, Japan |
| 17.00 | 32 |
"A novel genetic regulator of skeletogenesis: osteochondrodystrophy (ocd)
gene in mice" L. Xu, D. Wu, B.R. Olsen and Y. Li Harvard School of Dental Medicine and Harvard Medical School, Boston, MA, USA |
| 17.10 | 33 |
"Regulation of osteoblast differentiation and apoptosis by Twist, a bHLH
transcription factor" P.J. Marie Laboratory of Osteoblast Biology and Pathology, INSERM U349, Lariboisière Hospital, Paris, France |
| 17.30 | 34 |
"Incomplete myristoylation in the protein noggin can causes Fibrodysplasia
ossificans progressiva" G. Lucotte *, K. Fontaine, O. Sémonin Center of Molecular Neurogenetics, Paris, France |
| 17.40 | 35 |
"Impact of bone morphogenetic protein antagonists on the skeleton" E. Canalis St Francis Hospital and Medical Center, Hartford, CT, and the University of Connecticut School of Medicine, Farmington, CT, USA |
| 18.00 | 36 |
"Sclerostin is an osteocyte-expressed negative regulator of bone formation" C. Lowik, P. ten Dijke1, R. van Bezooijen Leiden University Medical Center and 1Netherlands Cancer Institute, The Netherlands |
| Thursday, November 27, 2003, 19.00 | ||
|
"Wine and
Dine" with the "Dance Fiddlers" | ||
| Friday, November 28, 2003 | TOP |
| 8.00 | 37 |
"Osteoclast differentiation and the role of Fos/AP-1 proteins" E.F. Wagner, R. Eferl, A. Hoebertz, L. Kenner, K. Matsuo IMP, Research Institute of Molecular Pathology, Vienna, Austria; 1Keio University School of Medicine, Tokyo, Japan |
| 8.30 | 38 |
"Effect of newly synthesized inverse NMDA-receptor agonists on osteoclast
attachment and bone resorption" O. Hoffmann, T. Pöhler, N. Djiometio, M. Berger, C. Noe Department of Pharmacology and Toxicology Department of Pharmaceutical Chemistry and Department of Brain Research, University of Vienna, Vienna, Austria |
| 8.40 | 39 |
"PKCalpha is downstream of alphaVbeta3 integrin and contributes to adhesion-induced
ERK1/2 activation in osteoclasts and in Chinese Hamster Ovary (CHO) cells" N. Rucci1, L. Orrù1, C. Di Giacinto1, S. Migliaccio1, M. Longo1, R. Baron2, A. Teti1 Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy, Department of Cell Biology and Orthopaedics, Yale University School of Medicine, New Haven, CT, USA |
| 8.50 | 40 |
"The selective estrogen receptor modulator LY117018 regulates osteoclast
generation in vitro" P. Pietschmann, G. Hofbauer, M. Peterlik Department of Pathophysiology, University of Vienna, Ludwig Boltzmann-Institute of Aging Research, Vienna, Austria |
| 9.00 | 41 |
"Increased cartilage loading controls chondroblastic differentiation via
potentiation of the JNK-AP-1 and ERK signal transduction pathways" D.J. Papachristou1,2, P. Pirttiniemi3, N. Agnantis2, A.G. Papavassiliou1, E.K. Basdra4, 1Department of Biochemistry, University of Patras School of Medicine, Patras, Greece, 2Department of Pathology, University of Ioannina School of Medicine, Ioannina, Greece, 3Institute of Dentistry, University of Oulu, Oulu, Finland, 4Department of Orthodontics, University of Heidelberg, Heidelberg, Germany |
| 9.10 | 42 |
"Hydrostatic pressure upregulates vitamin D3 synthesis by macrophages
in vitro" C.E. Evans, S. Mylchreest, A. Mee, J.A. Berry, G. Andrew University of Manchester, UK |
| 9.20 | 43 |
"The osteoclast: a lesson from osteopetrosis" A. Teti Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy |
| 9.40 | 44 |
"Molecular genetics of sclerosing bone dysplasias" W. Van Hul Department of Medical Genetics, University of Antwerp, Belgium |
| 10.00 - 10.30 | Coffee Break - Poster Viewing |
| 10.30 | 45 |
"Atorvastatin inhibits LRP5-mediated ectopic bone formation in the aortic
valves of hyperlipidemic rabbits" N.M. Rajamannan, M. Subramaniam, J.P. McConnell, R.J. Singh, T.J. Sebo,.S.R. Stock, R.O. Bonow, T.C. Spelsberg Northwestern University,Chicago IL, Mayo Clinic Rochester MN, USA |
| 10.40 | 46 |
"LRP5 and bone mass regulation through mechanical loading" M.L. Johnson Osteoporosis Research Center, Creighton University School of Medicine, Omaha, NE, USA |
| 11.10 | 47 |
"Mechanical loading of bone: bridging the gap between animal and human
studies" H.C.G. Kemper VU University Medical Center, EMGO Institute, Amsterdam, The Netherlands |
| 11.30 | 48 |
"Assessment of bone strength" D. Felsenberg Centre Muscle & Bone Research, Charité - University Medicine Berlin, Campus Benjamin Franklin, Freie Universität & Humboldt-Universität zu Berlin, Germany |
| 11.50 | 49 |
"Disease and ageing effects on bone renewal: influences on the mechanical
properties of the skeleton" J. Reeve, J. Power, P. Mayhew, D. Thomas*, S. Kaptoge, N. Loveridge University Department of Medicine, Addenbrooke's Hospital Cambridge, UK, *The University of Melbourne School of Dental Science, Melbourne, Australia |
| 12.10 | 50 |
"Bone quality at material level as defined by concentration, size, shape,
and alignment of mineral particles" P. Roschger1, H.S. Gupta1,3, M. Weber1,2, A. Valenta1,2, B.M. Misof1, S. Schratter2, I. Jäger2, K. Klaushofer1, P Fratzl3 1Ludwig Boltzmann Institute of Osteology, 4th Med. Department, Hanusch Hospital and Traumatology Center Meidling, Vienna, Austria, 2Erich Schmid Institute of Materials Science, Austrian Academy of Sciences and Institute of Metal Physics, University of Leoben, Leoben, Austria, 3Max Planck Institute of Colloids and Interfaces, Dept. Biomaterials, Potsdam, Germany |
| 12.20 | 51 |
"Long-term treatment with risedronate preserves bone quality" E.P. Paschalis1, R. Phipps2 1Ludwig Boltzmann Institute of Osteology, 4th Medical Department, Hanusch Hospital and UKH-Meidling Vienna, Austria, 2Procter & Gamble Pharmaceuticals, Mason, OH, USA |
| 12.30 | 52 |
"Decreased bone hardness in hip fracture: regional changes and the association
with bone remodelling" N. Loveridge, E. Follon*, J. Power, J. Reeve, W. Bonfield* Bone Research Group (MRC), *Dept of Materials, University of Cambridge, Cambridge, UK |
| 12.40 | 53 |
"Sex hormones, physical growth and bone quality in girls during puberty" W. Furmaga-Jablonska, B. Kulik-Rechberger, *J. Walawski, M. Kozlowska, *M. Jablonski Department of Developmental Paediatrics, *Department of Orthopaedics, Medical University of Lublin, Poland |
| 12.50 | 54 |
"The effects of remodelling on mechanical properties: pluses and minuses" J. Currey Department of Biology, University of York, York, UK |
| 13.20 - 13.30 | Break |
| 13.30 | 55 |
Awarding of the "2003 International Research Prize" of
the AuSBMR (sponsored by VIATRIS Pharma) "Prize Lecture" "Bone Diseases, T cells, and Mammalian Evolution" J.M. Penninger IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria |
| Satellite Symposia | TOP |
| 14.30 - 16.00 |
Satellite I (sponsored by Aventis) "Osteoporose - Rechtzeitig erkennen und behandeln" "Fehlerquellen beim Management der Osteoporose" G. Finkenstedt Univ. Klinik für Innere Medizin, Klinische Abt. für Allgemeine Innere Medizin, Innsbruck, Austria "Die Osteoporose beim Mann: Wie erkennen wir sie, was sind unsere therapeutischen Möglichkeiten?" J. Ringe Medizinische Klinik 4, Allgemeine Innere Medizin, Klinikum Leverkusen, Germany "Risedronat: Die neuesten Daten" H. Dobnig Medizinische Universitätsklinik, Klinische Abteilung für Endokrinologie und Nuklearmedizin, Graz, Austria |
| 16.30 - 18.00 |
Satellite II (sponsored by Merck Sharp & Dohme) "Osteoporose: Chancen und Grenzen der therapeutischen Intervention" "Osteoporose beim geriatrischen Patienten" P.M. Bernecker Geriatriezentrum der Stadt Wien, Baumgarten und St. Rochus, Vienna, Austria "Was ist eigentlich Knochenqualität?" D. Felsenberg Zentrum Muskel- und Knochenforschung, Freie Universität und Humboldt-Universität Berlin, Germany "Brauchen wir noch Antiresorptiva?" L. Erlacher A. ö. Krankenhaus der Elisabethinen, Interne Abteilung, Klagenfurt, Austria |
| Friday, November 28, 2003, 20.00 | |
|
Gala Reception
and Concert in the Wiener Konzerthaus | |
| Program | |
| W. A. Mozart: | 1st
Movement of the Symphony in A-Major, KV 201 Allegro moderato Concert in A-Major for Violin and Orchestra, KV 219 Allegro aperto Adagio Rondo - Tempo di Menuetto |
| Special
lecture: "A view from Central Europe on the EU and US: a clash of civilizations?" Dr. Erhard Busek, Former Vice Chancellor, Special Representative of the Stability Pact for Southeastern Europe, Chairman of the Institute for the Danube Region and Central Europe, Vienna, Austria | |
| J. S. Bach: | Nun
komm, der Heiden Heiland, BWV 62 Kantate for soloists, chorus and orchestra for the "1. Adventsonntag" |
| Performer: | Violin:
Wolfgang David Soloists and chorus: Students of Margit Klaushofer O-Ton Ensemble, Vienna Director: Ewald Donhoffer |
| Buffet | |
| (contribution towards expenses per person: EUR 15.-) | |
| Saturday, November 29, 2003 | TOP |
| 8.30 | 56 |
"Bone and tumour factors in breast cancer metastasis" T.J. Martin, M.T. Gillespie, M.A. Henderson St. Vincent's Institute of Medical Research, Melbourne, Australia |
| 9.00 |
Awarding of the "Herbert Czitober-Prize" of the AuSBMR
(sponsored by Merck Sharp & Dohme) Previous Prize Winners: 1996 B. Lanske (Martinsried), 1997 H. Dobnig (Graz), 1998 H. Glantschnig (Vienna), 1999 L. Erlacher (Vienna), 2000 B. Obermayer-Pietsch (Graz), 2001 R. Gruber (Vienna), 2002 B. Grabner (Vienna) | |
| 9.30 | 57 |
"Managing
osteoporosis after WHI" M. Gass Obstetrics & Gynecology, University of Cincinnati, Ohio, USA |
| 10.00 - 10.30 | Coffee Break - Poster Viewing |
| 10.30 |
11. Österreichisches Osteoporoseforum Begrüßung und Eröffnung durch G. Leb (Graz) | |
| 10.35 | "Osteoporosediagnostik
und Risikostratifizierung - was gibt es Neues?" G. Finkenstedt (Innsbruck) | |
| 10.55 | "Stellenwert
der Knochenumbaumarker in der Osteoporosediagnostik und -therapie" P. Bernecker (Vienna) | |
| 11.15 | "Knochenstoffwechsel
bei gastrointestinalen Erkrankungen" H. Resch (Vienna) | |
| 11.35 | "Glukokortikoide
und Knochen: was tun?" P. Pietschmann (Vienna) | |
| 11.55 | "Etablierte
Therapieansätze in der Behandlung der Osteoporose" H.P. Dimai (Graz) | |
| 12.15 | "Parathormon
- eine neue Behandlungsform für die schwere Osteoporose" H. Dobnig (Graz) | |
| 12.35 | Farewell | |
| 12.45 | Generalversammlung der ÖGEKM |
| Posters | TOP |
| P 1 | "In
vitro and in vivo evaluation of the angiogenetic potential of mesenchymal progenitor
cell-derived condition medium" +B. Kandler, #P. Holzmann, §R. Ullrich, $M. Vögele-Kadletz, #U. Losert, +G. Watzek, +R. Gruber +Department of Oral Surgery, Dental School, University of Vienna, Austria, #Department of Biomedical Science, University of Vienna, Austria, $Department of Surgery, University of Vienna, Austria, §Department of Pathology, University of Vienna, Austria |
| P 2 |
"Osteocalcin mRNA is detectable in hypertrophic chondrocytes of the epiphyseal
growth plate in mice" K. Nawrot-Wawrzyniak1, F. Varga1, A. Nader 1,2, N. Fratzl-Zelman1, M. Rumpler1, K. Klaushofer1 1Ludwig Boltzmann Institute of Osteology, 4th Med. Dept. Hanusch Hospital, Vienna, Austria, 2Institute for Pathology, Hanusch Hospital, Vienna, Austria |
| P 3 |
"Enzyme immunoassay for cathepsin K in human serum and plasma" G. Hawa1, I. Kryzer1, M. Skoumal2, K. Glatz1, G. Kolarz2, W. Woloszczuk1 1Biomedica Medizinprodukte GmbH & Co KG, Vienna, Austria, 2Institut für Rheumatologie der Kurstadt Baden in Kooperation mit der Donauuniversität Krems & Rheumasonderkrankenanstalt der SVA der gewerblichen Wirtschaft, Baden, Austria |
| P 4 | "Porous
hydroxyapatite scaffolds constructed by microstereolithography are suitable substrates
for osteoblasts" M. Rumpler1, A. Wöß2, F. Varga1, J. Stampfl3, N. Fratzl-Zelman1, P. Roschger1, P. Fratzl2, K. Klaushofer1 1Ludwig Boltzmann Institute of Osteology, 4th Med. Dept. Hanusch Hospital, Vienna, Austria, 2Max Planck Institute of Colloids and Interfaces, Dept. Biomaterials, Potsdam, Germany, 3Institute of Materials Science and Testing, Vienna University of Technology, Austria |
| P 5 | "Osteoporosis
and local variations in material properties" M. Weber1,2, P. Roschger1, J. Reeve3, N. Loveridge3, P. Fratzl2, K. Klaushofer1 1Ludwig Boltzmann Institute of Osteology, 4th Medical Department, Hanusch Hospital, Vienna, Austria, 2Erich Schmid Institute of Material Science, Austrian Academy of Sciences, and University of Leoben, Austria, 3Bone Research Group (MRC), Department od Medicine, University of Cambridge, UK |
| P 6 | "Comparison
of quantitative heel ultrasound with osteodensitometry in postmenopausal women
with Colles' fracture" G. Tautermann, P. Langer, A.Gohm*, R. Zinnecker*, K. Benedetto*, H. Drexel, G. Hoefle Department of Internal Medicine, Department of Traumatology*, Academic Teaching Hospital Feldkirch, Feldkirch, Austria |
| P 7 | "PvuII
polymorphisms of the estrogen receptor gene and bone mineral density in Beijing
Han women" Y. Xue, D. Li, Q. Wang et al Institute of Traumatology & Orthpaedics,Beijing Ji Shui Tan Hospital, Beijing, China |
| P 8 | "Relationship
between various measures of bone mineral density and vertebral fracture risk in
cardiac transplant recipients" G. Höfle, C.H. Säly, G. Tautermann, S. Aczél, H. Holzmüller, H. Drexel Department of Internal Medicine and VIVIT Institute, Academic Teaching Hospital Feldkirch, Feldkirch, Austria |
| P 9 | "Osteoporosis
and renal osteodystrophy - osteoprotegerin indicates difference in bone turnover" V. Kusec, K. Bilic, J. Jelcic, Z. Giljevic, R. Smalcelj, D. Kastelan, Z. Perkovic, M. Korsic, T. Szekeres Clinical Hospital Centre Zagreb, Zagreb, Croatia, General Hospital of Vienna, Vienna, Austria |
| P 10 | "Does
nutritional status in children influence bone metabolism?" W. Furmaga-Jablonska, E. Pac-Koluchowska, M. Kozlowska, *G. Polkowska Department of Developmental Paediatrics, *Department of Neonatal, Infants' Pathology and Cardiology, Medical University School of Lublin, Poland |
| P 11 | "Hip
arthropathy in long-term (20 or more years) hemodialysis patients" T. Nakai, K. Masuhara, N. Kanbara Department of Orthopaedic Surgery, Osaka Police Hospital, Kitayama-cho, Tennoji-ku, Osaka, Japan, Department of Orthopaedic Surgery, Osaka Kosei-nenkin Hospital, Fukushima, Fukushima-ku, Osaka, Japan, Department of Internal Medicine, Kanbara Hospital, Takakura-choh, Miyakojima-ku, Osaka, Japan |
| P 12 | "The
draft design of a rehabilitation aid for patients with acute painful fractures
of vertebrae" J. Wendlová Osteological Clinic, Derer´s University Hospital and Policlinic, Bratislava, Slovakia |
| P 13 | "Combined
use of risedronic acid andraloxifene in postmenopausal osteoporosis" A. Bazarra *, A. Castro ** Health Sciences* and Medicine** Dept, University of La Coruña, Spain |
| P 14 | "Ceramic
hydroxyapatite: bone defects filling material" A. Shchurovsky, J. Jackevych, B. Romanyshyn, I. Shchurovska, A. Shyyka Department of Surgery, Regional Specialised Children's Hospital, Lviv, Ukraine |
| P 15 | "Effect
of intermittent three-month treatment with different doses of ukrain on subregional
femoral bone mineral density of the sexually mature female rats" M. Gorzelak1, M. Jablonski1, M. Patyra1, E. Jagielo-Wójtowicz2 Department of Orthopaedics1, Department of Toxicology2, Medical University School, Lublin, Poland |
| P 16 | "Effect
of intermittent three-month treatment with different doses of ukrain on subregional
bone mineral density of the femur of ovariectomized rats" M. Jablonski1, M. Gorzelak1, M. Patyra1, E. Jagielo-Wójtowicz2 Department of Orthopaedics1, Department of Toxicology2, Medical University School, Lublin, Poland |
| TOP |
| The
organizers acknowledge the following companies, organizations and individuals
for their support Amgen Aventis Pharma Eli Lilly Merck Sharp & Dohme Novartis Roche Servier Austria Viatris Pharma Vienna Convention Bureau |
|
|  | |||||||||
|
|
| |||||||||
